Clover Health (CLOV) today announced its latest internal restructuring and appointment of Mark Herbers as Interim Chief Financial Officer following the decision of prior CFO Joseph Wagner to step down. Shares of the company were trading 0.55% lower to $8.18 a share on Monday.